chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Erythema; Hives; Swelling arm; Itch; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Erythema), PRURITUS (Itch), URTICARIA (Hives), PERIPHERAL SWELLING (Swelling arm) and VACCINATION SITE PAIN (Vaccination site pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On 21-Mar-2021, the patient experienced PRURITUS (Itch). On 22-Mar-2021, the patient experienced ERYTHEMA (Erythema), URTICARIA (Hives) and PERIPHERAL SWELLING (Swelling arm). The patient was treated with DIPHENHYDRAMINE at a dose of 1 dosage form. At the time of the report, ERYTHEMA (Erythema), PRURITUS (Itch), URTICARIA (Hives), PERIPHERAL SWELLING (Swelling arm) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were high blood pressure medication.
Patient stated while showering the am of 1/4 noticed a red area over COVID vaccine injection site. As the day went on, she became itchy all over and developed a rash.  Describes redness of injection site, pain in lymph nodes in armpit, diffuse itching
Not an adverse event, patient had received dose 1 and 2 of Moderna. Came in for booster and received Pfizer in error. Moderna has not been approved for booster, so no dose should have been administered.
Pt received vaccines on 8/31/12 and didn't feel well 3 days later. Was hospitalized & went into a coma on 9/3/12 for 2 weeks. Patient is doing well now.
A couple of days after receiving the second dose, I started to have lumps under my left arm. About three weeks after receiving the second dose, I started to form a vaginal abscess. I went to the Hospital ER on 03/19 where they lanced and packed the abscess. The ER gave me an antibiotic to take. Then on Monday, 03/22, I went to my surgeon, He removed the packing and checked the area. I went back to my surgeon on 03/29 for a check-up. The abscess was going away, but it was not totally gone. In April, The Surgeon, told me that if anything else appears, he would call more antibiotics for me. April 12th, I had another abscess appear in a different area on my vagina. The doctor said that he could remove the cyst if it was only appearing in one area, but it appeared in a different area. I did not have it lanced. I went back on 05/12 to my surgeon and he gave me more antibiotics. I had another abscess appear. I went back to the doctor and received more antibiotics. I had to go back on 06/24 for a check-up. Around the middle of July, I had noticed a 5th abscess had appeared. I went to see my GYN on 08/09 and he sent me to the dermatologist. She put me on antibiotics and two ointments, clindamycin lotion and nystatin cream 30g, apply as needed for redness. I went to my PCP, on 08/23, and that is when he did the blood work to determine that there were four different blood tests that determine immunity. Two of them were below the range, and the other tests were even lower. He sent me to an immunologist. I saw the immunologist and dermatologist on 10/12. The dermatologist took a biopsy. She provided the results and could only tell me what I didn't have. The dermatologist had a prescription compounded, triamcinolone 0.1% cream, as needed for any redness. I have not had to use this for the past five days.
Progressive symmetrical facial and upper extremity muscle weakness that worsened over the course of two weeks and has persisted with fluctuation since; Progressive symmetrical facial and upper extremity muscle weakness that worsened over the course of two weeks and has persisted with fluctuation since; This is a spontaneous report from a contactable reporter (other healthcare professional). The reporter is the patient.  A 36-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 24Dec2020 at 18:00 (Lot number: EK9231) at the age of 36 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: Mild intermittent asthma and "Penicillin allergy" (unspecified if ongoing), notes: known allergies: penicillin. There were no concomitant medications. The following information was reported: FACIAL PARESIS (non-serious), MUSCULAR WEAKNESS (non-serious) all with onset 29Dec2020 at 12:00, outcome "not recovered",  both described as "Progressive symmetrical facial and upper extremity muscle weakness that worsened over the course of two weeks and has persisted with fluctuation since". The event "Progressive symmetrical facial and upper extremity muscle weakness that worsened over the course of two weeks and has persisted with fluctuation since" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of facial paresis and muscular weakness.  Additional Information: Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. At the time of this report the patient still had symmetrical facial and upper extremity muscle weakness. Since the vaccination, the patient had been tested for COVID-19.
Booster received on 2/5 from the pharmacy. 2/19 I started to experiencing itchy skin that would welt and turn red. Itching has not eased at this time. Itching will come and go in waves. However, whenever I do itch skin becomes extremely inflamed, red to the touch and covered in welts.
This spontaneous report as received from a certified medical assistant (also provided as nurse) refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history and concurrent conditions was provided. On unknown dates between 06-AUG-2016 and 09-AUG-2016, the patients were vaccinated with improperly stored doses of M-M-R II injection, lot # L027431, expiration date: 22-JUL-2017 and lot # L036853, expiration date; 24-SEP-2017, (dose, dose number, route of administration and injection site were not provided). There were no concomitant medications reported. It was stated that the vaccine underwent temperature excursion of 48 degrees Fahrenheit for 1 hour 6 minutes. The temperature excursion was captured using digital data logger. No previous temperature excursion was reported. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
12 year old patient felt light headed and dizzy and blurred vision, then vision went black for a few seconds. sat down and given water and and within a couple of minutes was feeling well enough to leave. All starting within 5 minutes of vaccination.
left and right hand feels like ring worms and also has the ring worms in the back; A spontaneous report was received from a healthcare professional concerning a 78-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events feels like ringworms in the left hand, feels like ringworms in the right hand, feels like ring worms in the back.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 27 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 02ELWA) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 30 Jan 2021, the patient experienced the event(s) feels like ringworms in the left hand, feels like ringworms in the right hand, feels like ring worms in the back.  Treatment details included Psoriasis cream.  Action taken with mRNA-1273 in response to the events was not reported.  On 6 Feb 2021 the outcome of event(s), feels like ringworms in the left hand was resolved. The outcome of event(s), feels like ringworms in the right hand, feels like ring worms in the back was unknown.
Initially noticed tingling in hands which turned into numbness in hands up to mid forearms.  Also c/o numbness around lips.
little achy painy; very low grade fever; This case was reported by a consumer and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.  On 3rd May 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced pain and low grade fever. On an unknown date, the outcome of the pain and low grade fever were recovering/resolving.   It was unknown if the reporter considered the pain and low grade fever to be related to Shingrix.  Additional details were provided as follows: The patient had reported for him/herself. The age group was not reported but was captured as an adult as per the vaccine indication. The age at vaccination was not reported. On an unknown date, in May 2021, after receiving Shingrix, the patient experienced mild symptoms of little achy pain and low-grade fever and just wondered if he/she could take Tylenol or Ibuprofen. The patient reported that, with some vaccines like Covid vaccine, the patient was told to not take any pain medication. At the time of reporting, the patient was fine and did not experience any major.
Pain in left arm began within 30 min. of injection and has lasted over 24 hours with radiation down into elbow,  wrist, hand and fingers.
The next morning child was crying and holding her stomach complaining of stomach pain. From September  24, 2019 every morning she wakes up and says " tummy hurts"  holding her stomach with both hands, crying from pain. I took patient to Dr. today October 3, 2019
patient woke the next morning with severe cramping in bilateral calves (7/10 on a 0-10 pain scale).  Had difficulty ambulating.  Pain continues to be present, however much improved (2/10).
this dose of vaccine will be repeated wiht new vaccine shot; this dose of vaccine will be repeated wiht new vaccine shot; lmpropely stored vaccine administered; via Intramuscular route; This spontaneous report was received from a nurse referring to unknown number of patients of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided.  Since 25-JUL-2021, the patients were vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (lot # T002847, expiration date 23-JAN-2022; strength, dose, route were not reported) for prophylaxis. Temperature excursion was 37.94 Fahrenheit degrees for 100 hours. There was no previous temperature excursion (product storage error).   This is a non-valid report due to lack of patients' identifier.   Follow up information has been received from the nurse on 20-SEP-2021. Upon receipt of follow up it was determined that the case was valid as the patient's identifiers were provided. This report concerned a 12 (also reported as 13) months old male patient. On 30-JUL-2021, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (first dose, lot #: T002847, expiration date reported as 23-JAN-2023, but upon internal validation established as 23-JAN-2022) intramuscularly in the left thigh for prophylaxis (product storage error and incorrect route of product administration). The vaccine was stored in clinical "praclice". No prescription drug was given for the events. The detected vaccine was removed immediately after contacting Merck. No future vaccine was administered. The patient was noticed and this dose of vaccine would be repeated with new vaccine shot (extra dose administered and circumstance or information capable of leading to medication error). Data logger was involved.   This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2109USA005101: US-009507513-2109USA005117: US-009507513-2109USA005154: US-009507513-2109USA005159: US-009507513-2109USA005161: US-009507513-2109USA005213: US-009507513-2109USA005225: US-009507513-2109USA005236: US-009507513-2109USA005265: US-009507513-2109USA005394: US-009507513-2109USA005405:
PATIENT PREVIOUSLY RECEIVED JANSSEN VACCINE IN FEBRUARY. NO SYMPTOMS PRESENTED AFTER ADMINISTRATION
I started having chills on 6/28 with a temp of 101.8.  I was also experiencing nausea, diarrhea with very little taste and smell.  I also had an uncontrollable cough and over all did not feel good at all with weakness as well.  The next day I went to the clinic and they did a COVID-19 test and I got the results back on 6/30 that I was positive.  I didn't get any prescriptions but I was advised to get MAB therapy and I got that at my home the Sunday on 7/3/22.  I still have fatigue, shortness of break, and have a cough.
Poor quality vaccine administered with no reported adverse event; Products were not good and needed to be returned with no reported adverse event; Initial information was received on 19-Apr-2023 regarding an unsolicited valid  non-serious case received from a physician.  This case is linked to case 2023SA129826.  This case involves Infant and unknown gender patient who involved in the products HIB (PRP/T) VACCINE [ACT-HIB] were not good and needed to be returned and poor quality vaccine administered with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received 0.5 ml dose of suspect products HIB (PRP/T) vaccine Powder and solvent for solution for injection (lot number: UJ756AAA, expiry date: 12-Aug-2023, strength, route administrative site: Unknown) for prophylactic vaccination (immunization).  On an unknown date the patient developed a non-serious products were not good and needed to be returned with no reported (product storage error) and poor quality vaccine administered with no reported adverse event (poor quality product administered) (latency: same day) following the administration of HIB (PRP/T) VACCINE.  No lab data reported.  Action taken: not applicable.  Outcome: Unknown for both the event products.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Based upon a negative immunity titer on post-offer evaluation on 5/10/06, 2 doses of varicella vaccine was recommended. Employee consented to vaccine and received 1 dose on 5/31/06. On 7/6/06, employee presented with c/o itching and painful lesion on left back which appeared to be a herpes-type rash. She was referred to her primary care provider for further evaluation and treatment. She returned to work on 7/17/06 with a diagnosis of shingles. She had completed a 7-day couse of antibiotics (she did not remember the name). I was unsure if this was a vaccine-related reaction.
Narrative: Patient received one dose of covid vaccine. Found deceased in home a couple weeks after. This is a 68 yo man with hx of multiple psychiatric comorbidities, newly diagnosed copd, htn, hld, cirrhosis of the liver. Wife concerned for drug use, requested toxicology report- results unknown to writer.
My sleep was suddenly interrupted by extreme chills and violent shivering followed by headache,  close to midnight the night of the vaccine. Had to get under a very hot electric blanket to calm down and stop the chills. Next day just felt worn out. Injection site still very sore even 3 days later. This was my 2nd shingles shot; I had no reaction the first time, other than the soreness at the injection site lasted about a week.
I had a stroke ON 10/21/21. I had no risk factors for stroke up until this point. They are calling this an unprovoked /paradoxical clot. This means that they do not know what caused the clot And given that there were no recent risk factors other than the vaccine booster I got A few days before, they could not prove or rule out that was the risk factor
Nausea; Vomiting; weakness; Bodyaches; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), VOMITING (Vomiting), ASTHENIA (weakness) and MYALGIA (Bodyaches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L75A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided). Concomitant products included PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), LISINOPRIL, PROPRANOLOL HYDROCHLORIDE (INDERAL) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced NAUSEA (Nausea), VOMITING (Vomiting), ASTHENIA (weakness) and MYALGIA (Bodyaches). At the time of the report, NAUSEA (Nausea), VOMITING (Vomiting), ASTHENIA (weakness) and MYALGIA (Bodyaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
had that shot and still got shingles!/ Suspected Vaccination failure; had that shot and still got shingles!; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient stated that, he or she also had the shot and still got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
MEDICATION ERROR; LOWER BACK PAIN; CRAMPING IN ARM; BLURRED VISION; CAN NOT DRIVE; CAN NOT WORK; NEED HELP FROM OTHERS TO CARE FOR CHILDREN; BOTH LEG PAIN; This spontaneous report received from a parent concerned a 40 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included shrimp allergy, non-smoker, and non alcohol user, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. no medical conditions as per patient and no medications.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1809887 expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. Concomitant medications included bnt 162 for prophylactic vaccination. On APR-2021, the subject experienced lower back pain. On APR-2021, the subject experienced cramping in arm. On APR-2021, the subject experienced blurred vision. On APR-2021, the subject experienced can not drive. On APR-2021, the subject experienced can not work. On APR-2021, the subject experienced need help from others to care for children. On APR-2021, the subject experienced both leg pain. On 10-APR-2021, the subject experienced medication error. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from lower back pain, cramping in arm, both leg pain, and blurred vision, and the outcome of medication error, can not drive, can not work and need help from others to care for children was not reported. This report was non-serious.
massive headache; felt nauseous; This is a spontaneous report from a contactable consumer (patient) based on the information received by Pfizer  for BNT162B2. A 61-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of bnt162b2 for COVID-19 immunization on unspecified date. The patient stated that he got his second shot for Covid and had a massive headache and felt nauseous. The outcome of the event was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
dizziness; weakness; the second dose ook the inflammation out of my lungs and I can breathe normally for the first time in months; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), ASTHENIA (weakness) and THERAPEUTIC RESPONSE UNEXPECTED (the second dose ook the inflammation out of my lungs and I can breathe normally for the first time in months) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COVID-19.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), ASTHENIA (weakness) and THERAPEUTIC RESPONSE UNEXPECTED (the second dose ook the inflammation out of my lungs and I can breathe normally for the first time in months). At the time of the report, DIZZINESS (dizziness) and ASTHENIA (weakness) had not resolved and THERAPEUTIC RESPONSE UNEXPECTED (the second dose ook the inflammation out of my lungs and I can breathe normally for the first time in months) outcome was unknown.            No concomitant medications were reported Treatment information was not provided Action taken with mRNA-1273 in response to the events were Not Applicable
This spontaneous case reported by a consumer, describes the occurrence of lingering fatigue in a 73-year-old male patient who received mRNA-1273 (batch# 026A21A and 019B21A) for COVID-19 immunization. No medical history reported. On Mar 9, 2021, patient received the first dose of mRNA-1273 intramuscular; 1 dosage form. On Apr 8, 2021, received the second dose of mRNA-1273 intramuscular; 1 dosage form. On Apr 8, 2021, patient experienced lingering fatigue. At the time of the report, lingering fatigue outcome: unknown. Concomitant product use and treatment information not provided.
Narrative: Type II diabetic with ESRD on hospice - died. He had received his 2nd Pfizer dose 7 months prior.
pt recvd vax 16NOV95;19NOV95 noted general weakness & canker sore in mouth;notified MD but declined to go to office because of weakness;next day husband found pt dead;
Vaccine given on Thursday.  Within an hour of receiving it I started with severe burning then induration, increased warmth, pain, redness, pain and warmth started spreading over my upper arm, lasted until Monday and my skin was left with a yellow discoloration as you might see with a bruise resolving.  Also severe itching present.     I have pictures of the progression.